B57

Pure Crypto. Nothing Else.

Asia crypto news

Jaynti Kanani Bids Farewell to the Daily Grind: A New Chapter for Polygon

Jaynti Kanani steps back from daily tasks at Polygon, focusing on new adventures while supporting the project from the sidelines.

From Mansion to Eco-Farm: The Transformation of Su Zhu’s $36 Million Property

Discover how Su Zhu’s luxury Singapore estate became an eco-farm amid legal battles and financial turmoil.

Yield Protocol Bows Out: A Gloomy Exit Amid DeFi Challenges

Yield Protocol announces shutdown amid dwindling demand and regulatory pressures. Explore the DeFi landscape’s challenges in this bittersweet farewell.

Ending the BUSD Era: What Binance Users Need to Know

Binance shuts down BUSD lending by October 2023, signaling big changes in stablecoin usage. Learn what’s next for crypto users.

Unveiling the Optimism Network’s Fault-Proof Testnet: A Leap Towards Decentralized Superchains

Explore the Optimism network’s testnet for fault-proof systems, enhancing decentralization and security in blockchain technology.

Unleashing the Superchain: OP Labs Introduces Groundbreaking Fault-Proof System

Discover how OP Labs is launching a fault-proof system for Optimism, leading towards a more decentralized Superchain.

Ripple Labs Triumphs Over SEC as Court Rejects Appeal

Judge Torres denies SEC’s appeal against Ripple Labs, setting the stage for an April 2024 trial amidst a remarkable market reaction.

The Evolution of Crypto Storage: Lessons Learned and Future Prospects

Explore the evolution of crypto storage with hardware wallets and the changing landscape of Bitcoin. Discover user experience improvements and future insights.

Osmosis Welcomes Bitcoin: A Revolutionary Step for Cosmos and DeFi

Discover how Osmosis is integrating Bitcoin into the Cosmos network, enabling seamless transactions with nBTC for a thriving DeFi ecosystem.

Binance Faces Class-Action Lawsuit Over Market Manipulation Allegations

Binance faces a lawsuit over allegations of market manipulation in the FTX collapse. Find out the latest in this ongoing legal battle.